Cited by 381Seaweed-derived Bioactive CompoundsPolysaccharides Composition and ApplicationsPolysaccharides and Plant Cell Walls

The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index; none of the 73 sources its claims cite is checked for support yet.

Fucoidans from brown seaweeds: an update on structures, extraction techniques and use of enzymes as tools for structural elucidation

Open access

Abstract

Fucoidan or fucoidans cover a family of sulfated fucose-rich polysaccharides, built of a backbone of L-fucose units, and characteristically found in brown seaweeds. Fucoidans have potential therapeutic properties, including anti-inflammatory and anti-coagulant activities, as well as anti-proliferative effects on cancer cells. Recent work has revealed distinct structural features of fucoidans obtained from different brown seaweed sources. Fucoidans are classically obtained from brown seaweeds by multi-step, hot acid extraction, but the structural and compositional traits, and possibly the bioactivity, of the fucoidan polysaccharides are significantly influenced by the extraction parameters. This review discusses the structural features of fucoidans, the significance of different extraction technologies, and reviews enzymatic degradation of fucoidans and the use of fucoidan-modifying enzymes for elucidating structural details of fucoidans. Mild extraction techniques coupled with the use of new tools such as enzymes can provide the much needed knowledge about structural characteristics of different fucoidan molecules and thus pave the way for a better understanding of the structural chemistry and bioactivities of fucoidans.

Overview

AI snapshot

Written from the paper’s full text.

TL;DR

This review synthesizes the structural diversity of fucoidans (fucose-containing sulfated polysaccharides, FCSPs) from brown seaweeds, arguing that extraction conditions strongly shape yield and composition and that no consistent "fucoidan" backbone exists. It also reviews fucoidan-modifying enzymes (fucoidanases, fucosidases) as tools for structural elucidation and discusses bioactivity and commercial prospects.

Key findings

  • Fucoidan structures vary by species and cannot be predicted by algal order; the prevalent core backbones are (1→3)-linked α-L-fucopyranose and alternating (1→3)/(1→4)-linked α-L-fucopyranosyls, with variable sulfate, acetate, and branch substitutions (Table 1).
  • Extraction parameters significantly affect yield and composition: in the authors' own single-step study on *Sargassum henslowianum*, temperature and time had positive effects and acid concentration a negative effect, with a maximal fucoidan yield of ~7% at 0.03 M HCl, 90 °C, 4 h; 0.2 M HCl broke polysaccharide integrity, lowering fucose at elevated time/temperature.
  • Historical extraction data: a single acid hydrolysis recovered ~50% (w/w) of theoretical maximum fucoidan, while three rounds recovered >80% of fucose; the triple-step protocol (0.1 M HCl, pH 2.0–2.5, 70 °C, 1 h ×3) gave crude fucoidans with 30–36% fucose, and *F. vesiculosus* product contained 44% fucose, 26% total sulfate, and 31% ash. Yields as % fucose of total seaweed fucose were *Pelvetia canaliculata* 76%, *F. vesiculosus* 62%, *Ascophyllum nodosum* 54%, *L. cloustoni* 20%.
  • Fucoidanases show specificity: an endo-1,3-α-fucoidanase from *Fucanobacter lyticus* degraded Laminariales fucoidans but not Fucales or Chordariales; enzymatic treatment of *Fucus distichus* fucoidan confirmed repeating disaccharide units [→3)-α-L-Fucp-(2,4-di-SO₃²⁻)-(1→4)-α-L-Fucp-(2-SO₃²⁻)-(1→].

Methods

  • Narrative review covering fucoidan structural chemistry, extraction technology history (1913–1950s onward), extraction-parameter effects, and fucoidan-modifying enzymes.
  • Includes the authors' own single-step extraction experiment using *Sargassum henslowianum* as a model brown seaweed, with HPAEC-PAD analysis of TFA hydrolysates; extraction parameters tested were acid concentration, time, and temperature.
  • Enzyme data are compiled from published studies (Table 4) and classified by cleavage pattern: type 1 (1→4)-α-L-fucoidan endohydrolase, type 2 (1→3)-α-L-fucoidan endohydrolase, and type 3 exo-acting α-L-fucosidase.

Limitations

  • Stated: no standardized purification procedure exists for fucoidans; the use of many different extraction techniques has exacerbated structural elucidation; the exact structural elements responsible for bioactivity remain unidentified; no pharmaceutical, dermatological, or nutraceutical applications have been officially approved.
  • Stated: heterogeneity within the same seaweed species can lead to pronounced differences in extracted products.
  • Evident from the text: as a narrative review it does not describe a systematic literature search or inclusion criteria, and the extraction-parameter findings derive largely from a single model species (*S. henslowianum*), limiting generalizability.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1039/c3ra23373a

Cites

50 of 50 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Verification

Claims the paper makes

0 of 73 cited sources checked · 0 supported · 0 flagged

Show all 51 claims

  • It may state two separate claims as one. 33
  • Probably not a substantial claim. 14
41 of 41
  • The paper relies on this without support.

    Fucoidan polysaccharides have potential therapeutic properties, including anti-inflammatory, anti-coagulant, and anti-proliferative effects on cancer cells.

    “Fucoidans have potential therapeutic properties, including anti-inflammatory and anti-coagulant activities, as well as anti-proliferative effects on cancer cells.”
    “Fucoidan polysaccharides exhibit a number of pharmaceutically interesting biological activities, including immuno-modulatory, anti-tumor, anti-inflammatory and anti-coagulant effects (to be discussed in more detail later).”
  • The paper relies on this without support.

    No standardized purification procedure is available for fucoidans at present.

    “but no standardized purification procedure is available for fucoidans at present.”
  • The paper relies on this without support.

    The heterogeneity of the structural make-up of seaweeds within the same species may lead to pronounced differences in the products extracted.

    “In addition, the heterogeneity of the structural make-up of seaweeds within the same species may lead to pronounced differences in the products extracted.”
3 of 3

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

  • Example fucose content falls outside the stated range

    Minor

    The passage says samples obtained by the procedure contained 30-36% fucose, then gives a product from the same protocol as an example containing 44% fucose.

1 of 1

Citations

Cites

Flagged first, then by citations

Show all 50 references

Research works printed but not linked: 4

  1. H. Kylin in Hoppe-Seyleŕs Zeitschrift für physiologische Chemie, 1913, vol. 83, p. 171
  2. H. Kylin in Hoppe-Seyleŕs Zeitschrift für physiologische Chemie, 1915, vol. 94, p. 337
  3. G. Lunde , E.Heen and E.Öy in Hoppe-Seyleŕs Zeitschrift für physiologische Chemie, 1937, vol. 247, p. 189
  4. Shin-ichi, 1992, Biosci., Biotechnol., Biochem., 56, 1829, 10.1271/bbb.56.1829 · DOI · Paper page

Cited by

Sorted by citations

Items 101–200 of 380

Metadata

Authors
Ale, M. T., & Meyer, A. S.
Affiliations
Technical University of Denmark (DK)
Corresponding author
Meyer, Anne S.
Venue
RSC Adv.
Published
2013
Volume
3
Issue
22
Pages
8131-8141
ISSN
2046-2069 (ISSN-L)
OpenAlex
W2165865189
Cited by
381
References
50
Citations by year
2026: 38 · 2025: 33 · 2024: 32 · 2023: 33 · 2022: 36 · 2021: 39 · 2020: 50 · 2019: 43 · 2018: 28 · 2017: 17 · 2016: 13 · 2015: 9 · 2014: 9
FWCI
15.78
Type
journal article
Language
en
Open access
Licence
cc-by
Locations
  • RSC Advances (publishedVersion, cc-by)
  • Technical University of Denmark, DTU Orbit (Technical University of Denmark, DTU) (submittedVersion, cc-by)
Topics
  • Life Sciences › Agricultural and Biological Sciences › Aquatic Science › Seaweed-derived Bioactive Compounds
  • Life Sciences › Agricultural and Biological Sciences › Food Science › Polysaccharides Composition and Applications
  • Life Sciences › Agricultural and Biological Sciences › Plant Science › Polysaccharides and Plant Cell Walls
Keywords
fucoidan, brown algae, polysaccharide structure, enzymatic degradation, structure elucidation, anti-inflammatory activity, anticoagulant activity, antiproliferative activity

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

A language model drew the claims from the paper on 2026-10-07, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-07 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review